Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice

Our results suggest that the CB2 receptor agonists might be clinically useful as an adjunct treatment against seizure spread and status epilepticus and concomitant oxidative stress, neurotoxicity and cognitive impairments.